Systemic reactions generally were mild and were slightly more likely among those receiving both vaccines compared with the COVID-19 mRNA booster alone.
Fourth COVID-19 vaccine dose safe for immunocompromised
Jul 18, 2022
Local and systemic reactions were reported less frequently after the fourth dose versus dose 3 of the primary vaccination series.